Skip to content Skip to footer
Subscribe Now
Viewpoints_Kate Flathers
VIEWPOINTS

Streamlining Pharmaceutical Claims: Kate Flathers from Kalderos in a Stimulating Conversation with PharmaShots

Shots:  Streamlining claims transactions remains a major challenge for pharmaceutical manufacturers. The financial leakage owing to non-compliant and duplicate claims costs manufacturers a fortune  Using Kalderos' Truzo platform, manufacturers can pay covered entities directly while maintaining transparency and compliance Kate Flathers, Chief Product Officer at Kalderos, addresses the need for a compliant model for claims…
April 17, 2025

Read more

VIEWPOINTS_Micah Litow_2023
VIEWPOINTS

Micah Litow shares insights from the 2023 Kalderos Annual Report on drug discount programs

Shots: Micah Litow, in a stimulating conversation with PharmaShots, shares insights from the 2023 Kalderos Annual Report on drug discount programs  Micah highlights the challenges the drug manufacturers, covered entities, and state payers face on account of US drug discount programs  Micah sheds light on how Kalderos' MDRP Discount Monitoring solution helps drug manufacturers prevent…
November 9, 2023

Read more

VIEWPOINTS_Kyle Forcier_2023
VIEWPOINTS

In a gripping conversation with PharmaShots, Kyle Forcier addresses the ways to avoid the challenges of the 340B program

Shots: Kyle Forcier, Sr. Director of Life Science Product Marketing at Model N, addresses the challenges of the 340B program and ways manufacturers can mitigate them and emerge stronger  340B, a US federal government plan, enables eligible healthcare organizations and covered entities to receive outpatient drugs from drug manufacturers at significantly low prices  Kyle recalls…
October 23, 2023

Read more